The Cannabist Denver facility closure will eliminate 50 jobs as the multistate cannabis operator continues restructuring after receiving Chapter 15 bankruptcy recognition earlier this year. The company filed a Worker Adjustment and Retraining Notification with Colorado officials on July 14, confirming that its cultivation and manufacturing site on Nome Street will permanently close in September 2026. The shutdown comes as Colorado’s cannabis industry continues facing lower sales, falling wholesale prices, and fewer licensed cultivators.
Key Takeaways
- Cannabist will permanently close a Denver cultivation and manufacturing facility.
- The closure will affect 50 employees, including 14 production technicians.
- The first layoffs are scheduled for September 11, 2026.
- Cannabist received Chapter 15 bankruptcy recognition in May.
- Colorado cannabis sales fell from more than $2.2 billion in 2021 to $1.3 billion in 2025.
Cannabist Denver Facility Closure Set for September
The company, formerly known as Columbia Care, disclosed the shutdown through a WARN filing submitted to the Colorado Department of Labor and Employment.
According to the notice, every employee working at the Nome Street site will be affected. The first separations are expected to begin on September 11, 2026, and the closure is expected to be permanent.
The 50 affected workers include 14 production technicians. Employees will continue receiving their base wages and benefits during the required 60-day notice period.
The Cannabist Denver facility closure is part of a broader effort by the company to reduce its operations, sell assets, and address significant debt.
Bankruptcy Restructuring Changes Cannabist Operations
Cannabist sought Chapter 15 bankruptcy recognition in Delaware in March 2026 after entering insolvency proceedings in Canada.
Those deals included the sale of its Virginia ownership interests for $130 million, an equity agreement involving its Ohio operations valued at $47 million, and an agreement covering Delaware assets worth $16.5 million.
Even after those transactions, Cannabist reportedly remained about $270 million in debt to lenders. The company and its Canadian subsidiary then entered insolvency proceedings under Canada’s Companies’ Creditors Arrangement Act.
In May, the U.S. Bankruptcy Court in Delaware granted Chapter 15 recognition to the Canadian case. That decision allowed the restructuring proceedings to receive legal recognition in the United States.
The case drew industry attention because cannabis operators have historically struggled to access federal bankruptcy protections. Cannabis remains listed as a Schedule I controlled substance, creating legal complications for companies seeking traditional bankruptcy relief.
Cannabist Continues Selling Assets
Before receiving U.S. recognition for its insolvency proceedings, Cannabist announced plans to sell certain production, manufacturing, distribution, and dispensary operations across several state markets.
On July 20, 2026, Vireo Growth Inc. announced a $35 million agreement to acquire certain Cannabist operations in Colorado, Illinois, Massachusetts, New Jersey, and West Virginia.
The proposed transaction is expected to include up to 25 dispensaries, one cultivation facility, and one production facility.
The Denver closure and Vireo agreement are separate developments, but both reflect Cannabist’s broader effort to reduce debt and shrink its operating footprint.
Colorado Cannabis Market Decline Adds Pressure
Cannabist entered Colorado through major acquisitions made near the height of the state’s cannabis market.
In 2020, the company acquired The Green Solution for $140 million, gaining 21 dispensaries and extensive indoor and outdoor cultivation space. It expanded again in 2021 by purchasing Medicine Man for $42 million, adding four dispensaries and another indoor cultivation facility.
Market conditions have changed sharply since those deals.
Colorado’s licensed dispensaries generated more than $2.2 billion in cannabis sales in 2021. By 2025, annual sales had fallen to about $1.3 billion, representing a 41% decline.
Wholesale cannabis prices also collapsed. The average market rate for wholesale flower exceeded $1,700 per pound in early 2021 before falling to around $574 per pound.
Lower wholesale prices may benefit retailers and consumers, but they create serious problems for cultivators operating large facilities with high labor, utility, and maintenance costs.
Denver Cannabis Closures Continue
Cannabist is not the only major operator reducing its Colorado presence.
Curaleaf closed most of its Colorado operations in 2023. Green Dragon later announced plans to close a 92,000-square-foot cultivation facility and 17 dispensaries. In March 2026, Pharmacann said it would close a nearly 190,000-square-foot Denver cultivation and processing facility, affecting 132 workers.
Colorado now has approximately 470 licensed adult-use cultivators, down from 817 in mid-2022.
That steep decline reflects a market where oversupply, falling prices, high operating costs, and weaker sales have made large cultivation facilities harder to maintain.
Conclusion
The Cannabist Denver facility closure reflects both the company’s financial restructuring and the wider challenges facing Colorado cannabis businesses. Fifty workers will lose their jobs as Cannabist sells assets, reduces debt, and pulls back from facilities acquired during stronger market conditions. With sales and wholesale prices still well below previous peaks, Colorado may continue seeing more consolidation and fewer large cultivation operations.
